Cargando…
Complement Receptor 1: Disease associations and therapeutic implications
Exaggerated complement activation is a key event in the pathogenesis of a range of autoimmune and inflammatory diseases. Complement Receptor 1 (CR1) has emerged as a molecule of immense interest in gaining insight to the susceptibility, pathophysiology, diagnosis, prognosis and therapy of such disea...
Autores principales: | Khera, Rohan, Das, Nibhriti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd. Published by Elsevier Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125513/ https://www.ncbi.nlm.nih.gov/pubmed/19004497 http://dx.doi.org/10.1016/j.molimm.2008.09.026 |
Ejemplares similares
-
Altered Expression of Complement Regulatory Proteins CD35, CD46, CD55, and CD59 on Leukocyte Subsets in Individuals Suffering From Coronary Artery Disease
por: Mishra, Nitesh, et al.
Publicado: (2019) -
Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications
por: Laarman, Alexander, et al.
Publicado: (2010) -
Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease
por: Trambas, Inez A., et al.
Publicado: (2023) -
Association of polymorphisms in angiotensin-converting enzyme gene with gestational diabetes mellitus in Indian women
por: Aggarwal, Parul, et al.
Publicado: (2016) -
Complement in neurological disorders and emerging complement-targeted therapeutics
por: Dalakas, Marinos C., et al.
Publicado: (2020)